The round also saw 1Crowd, Stanford Angels and other angel investors participate.
The funds will be used to strengthen the technology behind Ivory’s clinical-grade assessments and also to scale up distribution.
Ivory wants to tap what it sees as a clear gap in the market. “Science says that, just as we lose muscle mass over time, our brain also shrinks in volume by about 5% every…








